Bessemer Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.8M | Sell |
116,101
-328
| -0.3% | -$11.8K | 0.01% | 672 |
|
|
2026
Q1 | $4.12M | Buy |
116,429
+36,940
| +46% | +$1.5M | 0.01% | 546 |
|
|
2025
Q4 | $3.23M | Buy |
79,489
+79,195
| +26,937% | +$3.45M | 0.01% | 618 |
|
|
2025
Q3 | $15K | Sell |
294
-13,982
| -98% | -$725K | ﹤0.01% | 1798 |
|
|
2025
Q2 | $743K | Sell |
14,276
-2,442
| -15% | -$134K | ﹤0.01% | 707 |
|
|
2025
Q1 | $1.01M | Sell |
16,718
-3,766
| -18% | -$243K | ﹤0.01% | 696 |
|
|
2024
Q4 | $1.4M | Buy |
20,484
+62
| +0.3% | +$4.32K | ﹤0.01% | 705 |
|
|
2024
Q3 | $1.47M | Buy |
20,422
+3,066
| +18% | +$216K | ﹤0.01% | 711 |
|
|
2024
Q2 | $1.2M | Hold |
17,356
| – | – | ﹤0.01% | 631 |
|
|
2024
Q1 | $1.39M | Buy |
17,356
+4,623
| +36% | +$412K | ﹤0.01% | 616 |
|
|
2023
Q4 | $1.4M | Buy |
12,733
+3,896
| +44% | +$403K | ﹤0.01% | 570 |
|
|
2023
Q3 | $891K | Buy |
8,837
+3,736
| +73% | +$429K | ﹤0.01% | 656 |
|
|
2023
Q2 | $693K | Buy |
5,101
+5,010
| +5,505% | +$612K | ﹤0.01% | 717 |
|
|
2023
Q1 | $9K | Buy |
+91
| New | +$8.8K | ﹤0.01% | 1490 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$1K | – | 1472 |
|
|
2020
Q3 | $1K | Sell |
18
-49,780
| -100% | -$4.06M | ﹤0.01% | 1301 |
|
|
2020
Q2 | $3.58M | Sell |
49,798
-61
| -0.1% | -$4.24K | 0.01% | 345 |
|
|
2020
Q1 | $2.86M | Buy |
49,859
+91
| +0.2% | +$8.39K | 0.01% | 363 |
|
|
2019
Q4 | $5.57M | Sell |
49,768
-2,651
| -5% | -$283K | 0.02% | 306 |
|
|
2019
Q3 | $5.04M | Sell |
52,419
-2,381
| -4% | -$224K | 0.02% | 297 |
|
|
2019
Q2 | $4.69M | Hold |
54,800
| – | – | 0.02% | 327 |
|
|
2019
Q1 | $4.56M | Buy |
54,800
+12,776
| +30% | +$928K | 0.02% | 285 |
|
|
2018
Q4 | $2.7M | Buy |
42,024
+14,100
| +50% | +$965K | 0.01% | 303 |
|
|
2018
Q3 | $2.21M | Hold |
27,924
| – | – | 0.01% | 377 |
|
|
2018
Q2 | $2.04M | Buy |
27,924
+273
| +1% | +$18.6K | 0.01% | 406 |
|
|
2018
Q1 | $1.75M | Buy |
27,651
+200
| +0.7% | +$11.9K | 0.01% | 440 |
|
|
2017
Q4 | $1.4M | Sell |
27,451
-11,211
| -29% | -$584K | 0.01% | 507 |
|
|
2017
Q3 | $2.03M | Buy |
38,662
+3,956
| +11% | +$199K | 0.01% | 439 |
|
|
2017
Q2 | $1.77M | Buy |
34,706
+34,300
| +8,448% | +$1.7M | 0.01% | 504 |
|
|
2017
Q1 | $18K | Hold |
406
| – | – | ﹤0.01% | 1460 |
|
|
2016
Q4 | $18K | Buy |
406
+244
| +151% | +$10.4K | ﹤0.01% | 1543 |
|
|
2016
Q3 | $6K | Hold |
162
| – | – | ﹤0.01% | 1608 |
|
|
2016
Q2 | $8K | Sell |
162
-2
| -1% | -$85 | ﹤0.01% | 1102 |
|
|
2016
Q1 | $7K | Hold |
164
| – | – | ﹤0.01% | 1189 |
|
|
2015
Q4 | $7K | Buy |
164
+114
| +228% | +$4.95K | ﹤0.01% | 1288 |
|
|
2015
Q3 | $2K | Buy |
+50
| New | +$2.75K | ﹤0.01% | 1457 |
|
Other funds holding CNMD
ICM
Bessemer Group's CNMD Position: Q2 2026 in Review
Bessemer Group reduced its CONMED (CNMD) stake by 0.28% in Q2 2026, selling an estimated $11.8K and leaving 116,101 shares worth $3.8M. The position accounts for 0.01% of the portfolio, ranked #672.
Bessemer Group first reported a position in CNMD in Q3 2015 and has held it in 35 quarters since. The position peaked at $5.57M in Q4 2019. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Bessemer Group held 116,101 shares of CONMED worth $3.8M as of Q2 2026.
- Bessemer Group sold 328 CONMED shares in Q2 2026, an estimated $11.8K.
- CONMED made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #672 holding.
- Bessemer Group first reported a position in CONMED in Q3 2015 and has held it in 35 quarters since.
- Bessemer Group's CONMED position peaked at $5.57M in Q4 2019.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.